The largest database of trusted experimental protocols

Superscript 4 reverse transcriptase kit

Manufactured by Thermo Fisher Scientific
Sourced in United States

SuperScript IV Reverse Transcriptase kit is a molecular biology product that enables the conversion of RNA into complementary DNA (cDNA) through the process of reverse transcription. The kit contains the essential components required for this process, including the SuperScript IV Reverse Transcriptase enzyme, buffers, and other necessary reagents.

Automatically generated - may contain errors

164 protocols using superscript 4 reverse transcriptase kit

1

Quantifying GLUT-3 Expression in Tissues

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was extracted from the tissue samples using TRIzol reagent (Invitrogen; Thermo Fisher Scientific, Inc.). The quality and quantity of RNA were assessed using the Agilent 2100 Bioanalyzer and NanoDrop ND-1000 Spectrophotometer (Agilent Technologies, Inc.). cDNA was synthesized from immunoprecipitated RNA using reverse transcriptase followed by second strand synthesis to generate double-stranded cDNA using SuperScript IV Reverse Transcriptase kit (Thermo Fisher Scientific, Inc.) under the following conditions: 25°C for 6 min, 55°C for 20 min, and 80°C for 10 min. The qPCR was performed using SsoFast™ EvaGreen® Supermix (Bio-Rad Laboratories, Inc.) according to the manufacturer's protocols. The GAPDH was used as an endogenous control, and fold changes were calculated via relative quantification (2−ΔΔCq). Transcripts were assessed using the following primers: GLUT-3 (forward, CAGCGAGACCCAGAGATGC; reverse, GACCCCAGTGTTGTAGCCAA) and GAPDH (forward, TGCACCACCAACTGCTTAGC; reverse, GGCATGGACTGTGGTCATGAG).
+ Open protocol
+ Expand
2

Quantifying Fungal Antioxidant Gene Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
C. albicans cells were grown in SC medium in the absence or presence of 800 μM BCS to an OD600 between 1.0 and 2.0. RNA was isolated from 20 OD600 cell units using an RNeasy mini kit (Qiagen), and then subsequently converted to cDNA using Superscript IV Reverse Transcriptase kit (Thermo Fisher Scientific). Real time PCR was performed as previously described [44 (link)]. cDNA was diluted 20-fold before PCR amplification with iQ SYBR Green Supermix (Bio-Rad) and values were normalized to TUB2 transcripts in each sample. The SOD3 and TUB2 primers were used as described [44 (link)]; AOX2 primers are GTTGGTCAAGGGGTTTTCACTAATG and ACTGCCACTTCAGGGATTTTCATGG.
+ Open protocol
+ Expand
3

RT-PCR Analysis of Blood mRNA

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was extracted from blood samples using the PAXgene Blood RNA Kit IVD (Qiagen). Polyadenylated mRNA was reverse transcribed into cDNA using the SuperScript IV Reverse Transcriptase Kit (ThermoFisher) with oligo d(T) primers. Primer sequences for the PCR on the synthesized cDNA are listed in the S4 Table. The products were analyzed on a Fragment Analyzer capillary gel electrophoresis instrument (Advanced Analytical). The sequence of the obtained RT-PCR products was confirmed by Sanger sequencing as described above.
+ Open protocol
+ Expand
4

Quantification of IGF-1 and miR-7515 Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was extracted from PC tissues and cell lines using TRIzol reagent (Invitrogen; Thermo Fisher Scientific, Inc.). mRNA was reverse-transcribed into cDNA using the SuperScript IV Reverse Transcriptase kit (Thermo Fisher Scientific, Inc.), while miRNA was reverse transcribed into cDNA using TaqMan™ MicroRNA Reverse Transcription kit (Thermo Fisher Scientific, Inc.). qPCR was subsequently performed using a PowerUp™ SYBR™ Green Master Mix (Thermo Fisher Scientific, Inc.). All the kits were used according to the manufacturer's instructions. GAPDH was used as the reference gene for IGF-1 expression, while U6 was used as the reference gene for miR-7515 expression. The following primer sequences were used for the qPCR: miR-7515, 5′-AGAAGGGAAGATGGTGAC-3′; IGF-1 forward, 5′-GCTCTTCAGTTCGTGTGTGGA-3′ and reverse, 5′-GCCTCCTTAGATCACAGCTCC-3′; GAPDH forward, 5′-GGAGCGAGATCCCTCCAAAAT-3′ and reverse, 5′-GGCTGTTGTCATACTTCTCATGG-3′; U6 forward, 5′-GCTTCGGCAGCACATATACTAAAAT-3′ and reverse, 5′-CGCTTCACGAATTTGCGTGTCAT-3′. The reaction conditions were as follows: 95°C for 10 min, followed by 40 cycles at 95°C for 1 sec and 60°C for 60 sec. Relative expression levels of the target mRNA or miRNA were determined using the 2−ΔΔCq method (19 (link)).
+ Open protocol
+ Expand
5

Plant RNA Extraction and qPCR Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was extracted from approx. 80 mg of frozen leaves using the ReliaPrep RNA Tissue Miniprep System (Promega) for fibrous tissues, with careful homogenization steps. RNA samples were quantified using a microvolume spectrophotometer (NanoDrop ND-1000, Thermo Scientific, USA). Purity was assessed by keeping ratios in between the following intervals: 1.8 < A260/280 < 2.3; 1.6 < A260/230 < 2.3. The extracted RNA was treated with DNase (DNase I Amplification Grade, Thermo Fisher Scientific) for 10 min at room temperature. Complementary DNA (cDNA) synthesis was synthesized using SuperScript IV Reverse Transcriptase kit (Thermo Fisher Scientific) and qPCR reactions were performed in a StepOnePlus Real-Time PCR System (Applied Biosystems), using 10 μl mix reaction composed of 5 μl Power SYBR green 2X (Thermo Fisher Scientific), 2 μl cDNA sample and 300 nM of forward and 300 nM of reverse primers. The amplification program consisted of 10 min initial step at 95 °C, followed by 40 cycles with 15 s 95 °C, 30 s 60 °C and 30 s 72 °C. In all cases, the melting curve was analyzed to detect unspecific amplification and primer dimerization. The relative transcript abundance was calculated by applying the 2−ΔΔCT method (Livak and Schmittgen 2001). All primer sequences used are listed in Supplementary Table S7.
+ Open protocol
+ Expand
6

Reverse Transcription of RNA from Platelets and FFPE Tissue

Check if the same lab product or an alternative is used in the 5 most similar protocols
Before synthesizing cDNA, the RNA from both platelets and tissue was subjected to a digestion process to remove contaminated DNA using DNAse I (1 U/µL) RNAse Free (ThermoFisher Scientific, CA, USA Cat No. EN0521) according to the manufacturer’s instructions.
The cDNA synthesis was performed on the purified and quantified RNA with the SuperScript™ IV Reverse Transcriptase Kit (ThermoFisher Scientific, CA, USA Cat No. 18091200). In the case of cDNA synthesis from platelet RNA, the supplier’s instructions were followed. In the case of cDNA synthesis from FFPE breast tissue samples, the protocol was as follows: incubation at 45 °C overnight, followed by incubation at 70 °C for 10 min. In both cases, oligo-random hexamer primers were used. The newly synthesized cDNA was stored at −70 °C until use.
+ Open protocol
+ Expand
7

Quantitative RT-qPCR Transcript Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
RNA was extracted using the RNeasy Mini Kit (Qiagen, 74104) according to the manufacturer's protocol; including an on-column DNA digest using RNase-free DNase (Qiagen, 79254). RNA concentration was determined using a NanoDrop spectrophotometer. Equal amounts of RNA were deployed to reverse transcription, using the SuperScript IV reverse transcriptase kit (Thermo Fisher Scientific, 18090200). Oligo(dT)15 primer (Promega, C1101) was used to specifically reverse transcribe polyadenylated transcripts. qPCR experiments were performed in technical duplicates and biological triplicates using a 384-well format on a Roche 480 Lightcycler instrument using the SYBR Green method (KAPA SYBR FAST qPCR Kit, Kapa Biosystems, KK4611). Fold change expression was calculated by the ΔΔct method. Gapdh was used for normalisation.
+ Open protocol
+ Expand
8

Quantitative Real-Time PCR Protocol for Angiogenesis Genes

Check if the same lab product or an alternative is used in the 5 most similar protocols
The nucleotide sequences of designed primers for the target and normalizer genes are shown in Table 1. Total RNA was extracted and purified using the Qiagen RNeasy Mini Kit (Cat. No: ID: 74104; Qiagen, Germany) according to the manufacturer's protocol. Quality and concentration assessments of the RNA samples were carried out using a Thermo Scientific NanoDrop One (Thermo Fisher Scientific Inc., Waltham, MA, USA). The Thermo Scientific SuperScript IV Reverse Transcriptase kit was used for cDNA synthesis. We chose the ABL gene as a normalizer gene, and relative expression of the Ang1, Ang2, Ang4, Tie1, and Tie2 genes were measured in BM samples of ALL patients and in normal samples. A total reaction volume of 15 mL was used for quantitative real-time polymerase chain reaction (qPCR). We used 7.5 mL of RealQ Plus Master Mix Green, without Rox (AMPLICON, Odense, Denmark) in each reaction, which was performed in the ABI StepOne Plus system in duplicates. As the first step of the qPCR, initial activation was performed at 95°C for 10 min. The thermal cycling program was carried out for 40 cycles with the following: denaturation (95°C for 10 s), annealing (58–64°C depending on the gene for 20 s), and extension (72°C for 30 s). After cycling, the final extension step (72°C for 10 min) was performed.
+ Open protocol
+ Expand
9

Accessory Gland RNA Extraction

Check if the same lab product or an alternative is used in the 5 most similar protocols
RNAs were isolated from accessory glands dissection, by Trizol-extracted total accessory glands (Invitrogen). Reverse transcription was performed by using SuperScript IV Reverse Transcriptase kit (ThermoFisher Scientific). Quantitative PCR was performed using on the LC480. rpl32 was used for the normalisation.
+ Open protocol
+ Expand
10

Madariaga Virus Genome Sequencing

Check if the same lab product or an alternative is used in the 5 most similar protocols
MADV was inactivated by TRIzol LS as described above, and RNA extraction was performed using the Zymo Research RNA Extraction Kit (Zymo Research, Irvine, CA, USA) following the manufacturer’s instructions. Complementary DNA (cDNA) was synthesized using the SuperScript IV Reverse Transcriptase Kit, using random hexamers and according to the manufacturer’s instructions (Thermofisher, Waltham, MA, USA). To amplify viral genomic material, an approximately 4kb DNA fragment (4022 bp) was amplified using Superfi II Polymerase with the following primers: MAD-F1-Forward ATAGGGTATGGTGTAGAGGCAGCCAC, MAD-F1-Reverse CCGGCCTCATACTGTGTGGAACC. The reaction mixture was annealed at 72 °C for optimal results. The virus was sequenced using the following primer: MAD-2664V CATAGATACCACGAGCACCACG. The identity of the virus was confirmed as Madariaga by running a BLAST search of the sequencing results.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!